Biomarkers and companion diagnostics expand drug potential
Essential for approving some new products, biomarkers are becoming integrated with patient therapies
A conversation with John M. Gray, Healthcare Distribution Management Assn.
PRODUCT SECURITY REPORT: Pharma track-and-trace inches closer to reality
Come September, all eyes will be on federal legislation that is close to final passage
Covance builds out its managed-markets advisory service
Company will provide services to manage data and terms of sales contracts
Supreme Court: reverse payment settlements subject to antitrust scrutiny
What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?
Worldwide, pharma distribution is moving to a serial-coded basis
Regardless of how pending US legislation is resolved, manufacturers need to move ahead
A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trends
Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations
The dynamic evolution of multi-sponsor REMS
Risk Evaluation & Mitigation Strategy (REMS) programs are evolving, with new complexities for compliance managers
Pharma distribution channels crank up for flu season
Newly commercialized vaccine-production methods could moderate the feast-or-famine uncertainties of vaccine supply
Take an enterprise view on serialization
Real business value arises from going beyond simple regulatory compliance for California's e-pedigree mandate
Protect your software investment with 'Training as a Service' (TaaS)
Why cloud-based software applications require a new training model
Meadwestvaco updates Shellpak with smaller profile
Better pharmacy stockroom efficiency, lower materials usage and patient convenience are benefits
CVS Caremark opens a $67-million, 400-employee mail-order pharmacy in Illinois
Highly automated facility can process 50 million prescriptions annually for CVS Caremark's book of business
FDA Secure Supply Chain Pilot Program raises its head
Agency will begin accepting applications for participants in the expedited import-clearance process in mid-September
Investment company targets specialty-pharma dispensing for business growth
Medworth Acquisition Corp. gathers $63.5 million in an IPO to fund an acquisition
Adherence programs need more than refill reminders
Effective programs need tailoring both to the specific drug and to patient needs, says Atlantis Healthcare
BDI Pharma targets specialty distribution with a unit-cost pricing model
Company touts double-digit growth in 'niche' distribution
Point-of-sale promotion generates a healthy financial return for pharma brands
New study documents the effectiveness of in-pharmacy promotion as a DTC marketing channel
United Air Cargo approves va-Q-tec passive containers for temperature-controlled shipping
Container supplier opens a US branch office to accommodate business growth
TransCelerate sets up a clinical trial network, speeding delivery of comparator drugs
The nonprofit industry R&D consortium addresses one of the difficulties of clinical trial administration
Product recalls business goes global
Stericycle's ExpertSolutions unit acquires a European marketing and recalls business
Big Three wholesalers round out their independent-pharmacy meetings with new business announcements
Cardinal Health's Retail Business Conference, ABC's ThoughtSpot and McKesson's IdeaShare meetings gather up independent pharmacist
FedEx offers a 96-hour, zero-pre-conditioning package for cold chain shipments
NanoCool technology needs neither batteries nor dry ice/gel packs for 2-8C shipping
GAO report lends support to drive to regulate drug compounding by FDA
GAO advises Congress to clarify FDA authority; tells FDA to do better at documenting inspections and tracking compounding pharmacies
Surprise! No federal law on track-and-trace or e-pedigree made it out of Congress before the summer recess
Outlook for successful Congressional action seems to hinge on what the House will do about compounding pharmacies
NEHI beats a drum for improved medication adherence throughout healthcare
Evidence-based tactics--supported by the pharma industry--are a targeted goal
Dohmen unloads its PBM business, Restat, to Catamaran for $409.5 million
Dohmen will focus more closely on services to life sciences companies
Almost half of all prescribers have restrictions on pharma rep access
ZS Associates report finds oncologists the most restrictive, with 65% placing moderate-to-severe limits
Symphony Health tangles with IMS Health over data access and pricing for information services
Lawsuit claims a violation of Sherman Antitrust Act
